France begins clinical trials of coronavirus blood plasma treatment

France is to begin clinical trials involving transfusions of blood plasma from coronavirus survivors into patients who have severe symptoms in a bid to treat the illness, the institutions involved said Saturday.

Drugmakers are racing to develop a vaccine and treatment for the pandemic, which has killed over 60,000 people since the coronavirus first emerged in China in December.

Plasma, the fluid in blood teeming with antibodies post-illness, has already proven effective in small studies to treat infectious diseases including Ebola and SARS.

The trials will involve 60 patients in Paris hospitals, half of whom will receive the plasma from the persons who have recovered.

It said the first results could be known two to three weeks after the trials.

The US Food and Drug Administration has already authorised physicians to experiment with the strategy to fight the coronavirus. Tests are also being done in China.

 

Source: https://tribune.com.pk/story/2193283/8-france-begins-clinical-trials-coronavirus-blood-plasma-treatment/

 

 

 

Share this page Share on FacebookShare on TwitterShare on Linkedin
Close

All the information about Covid-19 in Bahrain

A special page has been created on FCCIB's website to gather all the relevant information regarding the outbreak of Covid-19 in the country

Close

Are you starting to export ?